
Marinus Pharmaceuticals Investor Relations Material
Latest events

Investor & Analyst 2024
Marinus Pharmaceuticals

Investor Presentation
12 Nov, 2024

Q3 2024
12 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Marinus Pharmaceuticals Inc
Access all reports
Marinus Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing and commercializing therapeutics to treat epilepsy with a focus on rare and orphan seizures, as well as neuropsychiatric disorders in the United States.
Key slides for Marinus Pharmaceuticals Inc


Investor & Analyst 2024
Marinus Pharmaceuticals Inc


Investor & Analyst 2024
Marinus Pharmaceuticals Inc
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
MRNS
Country
🇺🇸 United States